Can mosaic embryos result in healthy babies?

Yes — many can. Outcomes data from multiple registries since 2017 (PGDIS, CoGEN, large clinic series) shows: low-level mosaic embryos result in healthy live births in approximately 40–50% of transfers. High-level mosaic embryos succeed in approximately 25–35% of transfers. Importantly, the babies born from mosaic transfers have been overwhelmingly chromosomally normal — the embryo apparently 'self-corrects' through preferential growth of the euploid cells.

Which chromosomes matter most when transferring a mosaic?

Chromosomes 13, 18, 21 (which can result in viable trisomies — Patau, Edwards, Down syndrome) and chromosomes X and Y (sex chromosome abnormalities) carry higher risk if mosaic transfer results in pregnancy with the abnormal cell line. Mosaicism for chromosomes that are not viable as full trisomies (most others) is generally lower-risk because abnormal cells either self-correct or result in early loss. Always discuss specific chromosome involvement with a genetic counsellor.

Are there miscarriage risks with mosaic embryos?

Yes — miscarriage rates are modestly higher with mosaic transfer (approximately 15–25%) versus euploid transfer (approximately 10–15%). High-level mosaics carry higher miscarriage risk than low-level. The risk is balanced against the alternative (no transfer at all if mosaic is your only option). Some couples choose to transfer mosaic embryos with the understanding that early loss is more likely; others choose another stimulation cycle to try for euploid embryos.

Does prenatal testing work after mosaic transfer?

Yes — and is strongly recommended. After mosaic embryo transfer that results in pregnancy, NIPT (non-invasive prenatal testing) at 10–12 weeks and CVS or amniocentesis at 11–13 or 15–18 weeks are typically offered. These confirm whether the resulting pregnancy is chromosomally normal. The vast majority of mosaic-transfer pregnancies that progress to NIPT show normal results, but confirmation is the standard of care.

Why are mosaic results becoming more common?

Two reasons. First, PGT-A laboratory technology has improved sensitivity, detecting subtle mosaicism that older platforms reported as euploid or aneuploid. Second, professional bodies (PGDIS, ASRM) updated reporting guidelines to formalise the mosaic category. So 'increase in mosaic embryos' largely reflects better detection rather than more biological mosaicism.

Mosaic Embryos: Should You Transfer? 2026 Outcomes and Decision Guide

Mosaic embryo results used to mean "do not transfer". Since 2017, accumulated outcomes data has shifted that thinking substantially — mosaic embryos can and frequently do result in healthy babies, and refusing to transfer them costs many couples successful pregnancies. This guide walks through what the current evidence supports, what the decision framework looks like, and the questions a good genetic counsellor will help you answer.

The headline: mosaicism is not a binary "normal or abnormal". It is a spectrum, and transfer decisions depend on mosaic level, chromosomes involved, alternative options, and your personal risk tolerance.

What is a mosaic embryo?

A mosaic embryo contains a mix of euploid (chromosomally normal) and aneuploid (abnormal) cells. PGT-A biopsies a small trophectoderm sample (5–10 cells) — when some cells are normal and others abnormal, the result is mosaic. Mosaic results are typically classified as low-level (20–40% abnormal cells) or high-level (40–80%). Below 20% is generally reported as euploid; above 80% as aneuploid.

Should I transfer a mosaic embryo?

Generally yes if you have no euploid embryos available and you understand the modestly lower success rates. Lean against if you have euploid embryos to transfer first, if mosaic level is very high, or if chromosomes 13, 18, 21, X, or Y are involved (these have known viable trisomy/sex chromosome implications). Every mosaic transfer decision should involve a genetic counsellor familiar with PGT-A interpretation.

What Mosaicism Actually Means

PGT-A samples 5–10 cells from the trophectoderm (the cells that will become the placenta). The lab sequences these cells and assesses chromosome copy numbers. Three result categories:

Euploid: All sampled cells appear chromosomally normal (under ~20% abnormal)
Mosaic: Mix of normal and abnormal cells (20–80% abnormal)
Aneuploid: All or nearly all sampled cells abnormal (over ~80%)

A subtlety worth understanding

PGT-A samples 5–10 cells from the trophectoderm — not the inner cell mass that becomes the baby. Mosaic results reflect what was in the biopsy sample, not necessarily what is in the rest of the embryo. This sampling limitation is part of why mosaic embryos often result in healthy euploid babies — the abnormal cells may be confined to the placenta and self-corrected through preferential euploid growth in the embryo proper.

Outcomes by Mosaic Level

Multiple registries and large clinic series since 2017 have published outcomes for deliberate mosaic embryo transfers:

Embryo type	Live birth rate	Miscarriage rate
Euploid	55–65%	10–15%
Low-level mosaic (20–40%)	40–50%	15–20%
High-level mosaic (40–80%)	25–35%	20–25%
Aneuploid	Very low	High

Crucially: babies born from mosaic transfers have been overwhelmingly chromosomally normal at birth. The mosaic biopsy result is not a prediction of what the baby will be — it is a statistical description of the biopsied cells.

Your IVF journey, organised and free

IVFPath is built for IVF patients — track medications, appointments, lab results, and costs all in one place.

💊

Medication Reminders

Never miss a dose — log every injection and tablet

📅

Appointment Calendar

All your scans, retrievals and transfers in one view

💰

Cost Tracker

Track spending so nothing is a surprise

Start for free — no card needed

Free · No credit card · Works on any device

Which Chromosomes Matter

Not all mosaicism carries equal risk. The chromosomes involved matter because some aneuploidies are viable in pregnancy:

Higher-risk chromosomes for mosaic transfer

• Chromosome 13: Patau syndrome (trisomy 13)
• Chromosome 18: Edwards syndrome (trisomy 18)
• Chromosome 21: Down syndrome (trisomy 21)
• X and Y chromosomes: Various sex chromosome aneuploidies (Klinefelter, Turner, etc.)

Lower-risk chromosomes

Mosaicism for most other chromosomes is generally lower-risk because the abnormality is not viable as a full trisomy — abnormal cells either self-correct or result in early pregnancy loss without ongoing health implications for the baby.

Deciding to Transfer or Not

Generally favours transfer

• No euploid embryos available
• Low-level mosaic (20–40%)
• Single chromosome mosaicism
• Lower-risk chromosomes involved
• Patient has had multiple cycles already
• Older patient with limited time for additional cycles

Generally favours waiting / not transferring

• Euploid embryos available — transfer those first
• High-level mosaic (over 60–70%)
• Multiple chromosome mosaicism
• Higher-risk chromosomes (13, 18, 21, X, Y)
• Younger patient with good reserve who can do another cycle

A useful frame

The right comparison is not "mosaic embryo vs guaranteed healthy baby" — it is "mosaic embryo with X% success vs another stimulation cycle with Y% chance of euploid embryos". For older patients, another cycle may not produce better embryos than what you have. For younger patients, it might.

Prenatal Testing After Transfer

If a mosaic transfer results in pregnancy, prenatal testing is strongly recommended:

NIPT (non-invasive prenatal testing) at 10–12 weeks: Checks fetal cell-free DNA in maternal blood for major aneuploidies; non-invasive, no miscarriage risk
CVS (chorionic villus sampling) at 11–13 weeks: Direct placental sampling; ~0.5% miscarriage risk
Amniocentesis at 15–18 weeks: Direct amniotic fluid sampling; ~0.3% miscarriage risk

Most clinics now offer NIPT as standard after mosaic transfer with confirmation by CVS or amnio if NIPT shows any abnormality. Discuss with your genetic counsellor and OB before the pregnancy progresses.

Working with a Genetic Counsellor

A genetic counsellor familiar with PGT-A interpretation should be involved in any mosaic transfer decision. They can:

Explain the specific mosaic profile of your embryo (which chromosomes, what level)
Quantify risks for your specific situation, not generic ranges
Help interpret your clinic's recommendation in light of current professional guidance
Coordinate post-transfer prenatal testing strategy

Trying to decide on a specific mosaic embryo?

Mosaic transfer decisions are highly individual. Nestie's AI assistant can help you understand your specific PGT-A report in plain language and prepare the questions to bring to your genetic counsellor and clinic.

Decode your PGT-A report with Nestie →

Frequently Asked Questions

References

Outcomes data drawn from PGDIS (Preimplantation Genetic Diagnosis International Society) position statements, CoGEN registry, large clinic series published since 2017, ASRM technical bulletins on PGT-A interpretation, and ESHRE good practice recommendations. Mosaic transfer policy is evolving — confirm current practice with your clinic and genetic counsellor.

Mosaic Embryos: Should You Transfer? A 2026 Decision Guide